IanFrederickParneyMD
Neurosurgery • Rochester, MNProfessor and Vice-Chair (Research), Neurologic Surgery, Mayo Medical School
Dr. Parney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Summary
- Ian Parney, MD is a neurosurgeon based in Rochester, MN, specializing in the treatment of glioblastoma, gliomas, and neurosurgical oncology, among others. A graduate from the University of Alberta (class of 1993), Dr. Parney has expertise in craniotomy and neurosurgical spine surgery. He has a strong publishing record, with his works appearing in journals such as BMC Cancer, Journal of Neurosurgery, Brain, and Nature Communications. He is also involved in several clinical trials primarily focusing on vaccine therapy for patients with recurrent glioblastoma.
Education & Training
University of AlbertaClass of 1993
Certifications & Licensure
CA State Medical License 2002 - Present
MN State Medical License 2008 - 2025- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 May 01
- Vaccine Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2013 Nov 27
Publications & Presentations
PubMed
- 105 citationsThe role of LAT1 in 18 F-DOPA uptake in malignant gliomasRyan S. Youland, Gaspar J. Kitange, Timothy E. Peterson, Deanna H. Pafundi, Judi Ramiscal
Journal of Neuro-Oncology. 2013-01-01 - 710 citationsPostoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, co...Paul D. Brown, Karla V. Ballman, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero
The Lancet. Oncology. 2017-08-01 - 70 citationsImmunosuppression in Glioblastoma: Current Understanding and Therapeutic ImplicationsBenjamin T. Himes, Philipp Geiger, Katayoun Ayasoufi, Adip G Bhargav, Desmond A Brown
Frontiers in Oncology. 2021-10-28
Journal Articles
- A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in GlioblastomaIan F Parney, Fredric B Meyer, Caterina Giannini, Jann N Sarkaria, Nature
Press Mentions
Living in the Present, Grateful for LifeJune 6th, 2018
Mayo Clinic Center for Regenerative Medicine to Co-Host World Stem Cell Summit 2016 Dec. 6-9December 1st, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
